Technology | December 11, 2012

AliveCor’s Heart Monitor for iPhone Receives FDA Clearance

Availability of mobile ECG will impact screening and treatment of heart conditions

AliveCor Heart Monitor iPhone

December 11, 2012 — AliveCor Inc. announced at the start of the 4th annual mHealth Summit in Washington, D.C., that it has received CE mark and U.S. Food and Drug Administration (FDA) 510(k) clearance on its mobile Heart Monitor. This clinical-quality, low-cost mobile electrocardiogram (ECG) heart monitor, compatible with the iPhone 4 and 4S, enables doctors to evaluate patient heart health easily, quickly and remotely.

Clinical studies of the device indicate that a high-quality single-channel ECG can be rapidly and simply recorded using an iPhone with the AliveCor application and device, to accurately screen for cardiac arrhythmias, including atrial fibrillation. Atrial fibrillation is the most commonly occurring arrhythmia and carries a five-fold increased risk of stroke.

Additionally, AliveCor’s founder, David Albert, and co-founders Bruce Satchwell and Kim Barnett were granted U.S. Patent No. 8,301,232 for the device and technology. The three colleagues began working on the heart monitoring device in 2008. “We believe that mobile ECGs and other breakthroughs in mobile health can significantly change the way medicine is delivered,” Albert said.

AliveCor’s Heart Monitor is initially intended for use by licensed medical professionals to record, display, store, transfer and evaluate single-channel ECG rhythms.

The rhythm strips can be of any duration, and are stored on the iPhone and securely in the cloud for later analysis, sharing and printing through AliveCor’s secure website. The ECG data is sent wirelessly from the Heart Monitor via AliveCor’s low-power, proprietary communication protocol, and requires no pairing between the iPhone and the device.

The device incorporates electrodes into a case that snaps onto the back of an iPhone 4 or 4S. The Heart Monitor is used by launching the corresponding AliveECG app on the iPhone, holding the device in a relaxed state, and pressing fingers from each hand to each of the two appropriate electrodes on the device. The device can also be used to obtain an ECG by placing it on the chest.

“Our goal is to make healthcare cheaper, easier and more readily available without losing quality of care,” said AliveCor president and CEO Judy Wade. “Our aspirations are significant; we’re out to make a real difference.”

AliveCor’s Heart Monitor is available for pre-sale to medical professionals in the United States through the company website at a cost of $199. AliveCor plans to begin selling the Heart Monitor in Europe in early 2013.

For more information: www.alivecor.com

Related Content

AliveCor and Omron are partnering to integrate Alivecor's mobile device ECG technology with Omron's wireless blood pressure monitoring technology on Remote Cardiovascular Monitoring into one platform for remote patient monitoring.

AliveCor and Omron are partnering to integrate Alivecor's mobile device ECG technology with Omron's wireless blood pressure monitoring technology on Remote Cardiovascular Monitoring into one platform for remote patient monitoring.

News | Remote Monitoring | April 24, 2020
April 24, 2020 — AliveCor and Omron Healthcare announced a global, strategic alliance that combines AliveCor's mobile
Eko Launches Eko Home Cardiac Remote Monitoring Application
News | Remote Monitoring | July 31, 2019
Silicon Valley-based digital health company Eko announced Eko Home, a new service that enables precise remote...
AT&T Demonstrates Connectivity With Smart Scale at HIMSS 2019
News | Remote Monitoring | February 21, 2019
At the recent Healthcare Information and Management Systems Society (HIMSS) annual conference, AT&T’s healthcare...
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices.

Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices. 

News | Remote Monitoring | February 19, 2019
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote...
Biotronik Named Exclusive U.S. Distributor of MoMe Kardia Diagnostic Monitor
News | Remote Monitoring | September 05, 2018
Biotronik announced it is now the exclusive U.S. distributor for the MoMe Kardia external cardiac diagnostic monitor...
Philips Acquires Xhale Assurance Inc.
News | Remote Monitoring | August 31, 2018
Philips announced it has acquired Xhale Assurance Inc., a U.S.-based scale-up company developing and commercializing...
The Biotricity Bioflux remote ECG monitoring system.
News | Remote Monitoring | July 24, 2018
July 24, 2018 - Diagnostic and consumer healthcare remote monitoring technology company Biotricity Inc.
LindaCare, expansion, remote patient monitoring, CIEDs, cardiac implantable electronic devices, United States
News | Remote Monitoring | January 18, 2017
LindaCare announced that it will open a new customer support facility in Connecticut to support growing interest in...
smartphone application, heart attack detection, University of Turku Finland
News | Remote Monitoring | October 28, 2016
A smartphone application developed by researchers at the University of Turku, Finland, can detect myocardial infarction...
Vital Connect, BePATIENT, BeVITAL remote monitoring system, HealthPatch MD

Vital Connect's HealthPatch MD wearable sensor, part of the BeVITAL remote monitoring system.

Technology | Remote Monitoring | June 08, 2016
Vital Connect Inc., developer of wearable biosensor technologies, and BePATIENT, a startup that develops patient-...